EP4704977A1 - Immunogene zusammensetzung zur selbstverabreichung durch schweine - Google Patents
Immunogene zusammensetzung zur selbstverabreichung durch schweineInfo
- Publication number
- EP4704977A1 EP4704977A1 EP24725954.2A EP24725954A EP4704977A1 EP 4704977 A1 EP4704977 A1 EP 4704977A1 EP 24725954 A EP24725954 A EP 24725954A EP 4704977 A1 EP4704977 A1 EP 4704977A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- immunogenic composition
- virus
- subject
- virus antigen
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physiology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Birds (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363499937P | 2023-05-03 | 2023-05-03 | |
| PCT/IB2024/054269 WO2024228148A1 (en) | 2023-05-03 | 2024-05-02 | Immunogenic composition useful for self-administration by pigs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP4704977A1 true EP4704977A1 (de) | 2026-03-11 |
Family
ID=91082061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP24725954.2A Pending EP4704977A1 (de) | 2023-05-03 | 2024-05-02 | Immunogene zusammensetzung zur selbstverabreichung durch schweine |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4704977A1 (de) |
| KR (1) | KR20260005383A (de) |
| CN (1) | CN121013728A (de) |
| AR (1) | AR132581A1 (de) |
| AU (1) | AU2024266173A1 (de) |
| CL (1) | CL2025003188A1 (de) |
| CO (1) | CO2025015952A2 (de) |
| MX (1) | MX2025012908A (de) |
| TW (1) | TW202509055A (de) |
| WO (1) | WO2024228148A1 (de) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| JP3795751B2 (ja) | 1997-12-11 | 2006-07-12 | ユニバーシティ オブ サスカッチェワン | ブタからの離乳後多全身系消耗症候群ウイルス |
| US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| KR101347503B1 (ko) | 2005-09-09 | 2014-01-02 | 인터벳 인터내셔널 비.브이. | Pcv-2 백신 |
| KR101030792B1 (ko) * | 2010-09-16 | 2011-04-27 | 주식회사 코미팜 | 돼지 써코바이러스2(pcv2) 유전자의 표면발현용 벡터 및 이로 형질전환된 살모넬라 백신 균주 |
| US9505808B2 (en) | 2013-10-02 | 2016-11-29 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 protein variant and virus like particles composed thereof |
| CN106399138B (zh) * | 2016-09-07 | 2019-11-12 | 复旦大学 | 猪圆环病毒ii型口服病毒样颗粒疫苗及其制备方法和应用 |
| US10485866B2 (en) | 2016-11-03 | 2019-11-26 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine against porcine parvovirus |
| PT3534939T (pt) | 2016-11-03 | 2023-04-20 | Boehringer Ingelheim Vetmedica Gmbh | Vacina contra parvovírus porcino e vírus da síndrome reprodutiva e respiratória porcina e métodos da sua produção |
| CN119488586A (zh) | 2018-03-26 | 2025-02-21 | 勃林格殷格翰动物保健美国有限公司 | 制备免疫原性组合物的方法 |
| KR20230164694A (ko) * | 2021-04-09 | 2023-12-04 | 카이코 가부시키가이샤 | 경구 백신 조성물 |
-
2024
- 2024-05-02 EP EP24725954.2A patent/EP4704977A1/de active Pending
- 2024-05-02 TW TW113116389A patent/TW202509055A/zh unknown
- 2024-05-02 WO PCT/IB2024/054269 patent/WO2024228148A1/en not_active Ceased
- 2024-05-02 AR ARP240101116A patent/AR132581A1/es unknown
- 2024-05-02 KR KR1020257040391A patent/KR20260005383A/ko active Pending
- 2024-05-02 AU AU2024266173A patent/AU2024266173A1/en active Pending
- 2024-05-02 CN CN202480025831.6A patent/CN121013728A/zh active Pending
-
2025
- 2025-10-17 CL CL2025003188A patent/CL2025003188A1/es unknown
- 2025-10-28 MX MX2025012908A patent/MX2025012908A/es unknown
- 2025-11-20 CO CONC2025/0015952A patent/CO2025015952A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR132581A1 (es) | 2025-07-16 |
| AU2024266173A1 (en) | 2025-12-11 |
| CO2025015952A2 (es) | 2025-11-28 |
| KR20260005383A (ko) | 2026-01-09 |
| WO2024228148A1 (en) | 2024-11-07 |
| CL2025003188A1 (es) | 2026-01-30 |
| TW202509055A (zh) | 2025-03-01 |
| MX2025012908A (es) | 2025-12-01 |
| CN121013728A (zh) | 2025-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2719483T3 (es) | Vacuna de combinación CVP/Mycoplasma hyopneumoniae/SRRP | |
| Chien et al. | Oral immunization with cell-free self-assembly virus-like particles against orange-spotted grouper nervous necrosis virus in grouper larvae, Epinephelus coioides | |
| ES2434117T3 (es) | Prevención y tratamiento de pcvd subclínica | |
| JP6876127B2 (ja) | ブタパルボウイルスに対するワクチン | |
| US11896659B2 (en) | Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof | |
| KR102802419B1 (ko) | 백신 제제, 및 어류의 이리도바이러스 감염증 예방 방법 | |
| AU2016222962A1 (en) | Bivalent swine influenza virus vaccine | |
| Van Oirschot | Vaccinology: Present and future of veterinary viral vaccinology: A review | |
| KR20170094186A (ko) | 즉시 사용가능한 pcv2/m.hyo 혼합 백신에 대한 방법 | |
| WO2024228149A2 (en) | Method for inducing an immune response | |
| JP7303306B2 (ja) | 口蹄疫ウイルス様粒子抗原及びそのワクチン組成物並びに調製方法及び応用 | |
| EP4704977A1 (de) | Immunogene zusammensetzung zur selbstverabreichung durch schweine | |
| US20250360189A1 (en) | Immunogenic gel compositions | |
| WO2021217982A1 (zh) | 口蹄疫病毒样颗粒抗原、及其疫苗组合物、制备方法和应用 | |
| BR112020017520A2 (pt) | Método para redução de escatol e/ou indol em animais | |
| CN108883169A (zh) | 针对pcv2和prrs病毒感染的皮内应用疫苗 | |
| JP2019509302A (ja) | アルブミンを含むpcv2及びprrsウイルス感染症に対する混合ワクチン |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
| 17P | Request for examination filed |
Effective date: 20251203 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR |